AUTHORS
Brad Ginesin
Recent Articles By The Author
Feeling Queasy Over Moderna's Outlook? Investors May Still Get Their Shot
With an expected dip for 2023, the pharmaceutical company could see its mRNA technology win big over the long term -- and investors could be rewarded.
The Best House in This Neighborhood Is on Sale
The buying opportunity here below book value is compelling.
Looking for a Bargain at Target? Then Check Out the Stock
As the big-box retailer's fortunes are turned upside down, TGT is almost 50% off the top -- and back to a reasonable valuation.
Create an Exit Plan for When Oil Stocks Run Out of Gas
Today's winning sector eventually will become tomorrow's loser, so think about when it's time to get out.
Redbox Could Produce Red Ink for Portfolios If Short Squeeze Fever Abates
Shares of the DVD kiosk and streaming video company have spurted higher, but buyers are playing with fire.
Are We Headed Down the Path to Investor Apathy, Not Opportunity?
The last place to invest is in assets where valuation is difficult to ascertain.
Generac, Once a Star Amid the Pandemic, Fell. Can It Keep Shining?
Let's look at this energy company that rode several trends to gain around 1,000% and then lose half its value after the 2021 top.
As Amazon Preps Its Stock Split, Let's See If It's Past Its Prime
Let's take a close -- and critical -- look at the dogmatic bullishness for Amazon. I did, and here's what surprised me.
Here's How to Wrangle JPMorgan, the '800-Pound Gorilla' of Banking
The financial services giant just held its first investor day in three years -- let's open the vault and see what's inside.
Boston Scientific Could Be Wicked Good in This Kind of Market
Here's why this healthcare stock is a potential port in the storm for investors.
Oops!
We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.
Please Join or Log In to Email Our Authors.
Email Real Money's Wall Street Pros for further analysis and insight
Already a Subscriber? Login